AWP
GILD icon

Ascent Wealth Partners’s Gilead Sciences GILD Stock Holding History

Ascent Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.99M Buy
+57,344
New +$8.03M 0.93% 34
2018
Q1 		– Sell
-8,121
Closed -$582K – 123
2017
Q4 		$582K Buy
8,121
+20
+0.2% +$1.52K 0.22% 82
2017
Q3 		$656K Hold
8,101
– – 0.26% 74
2017
Q2 		$573K Buy
8,101
+148
+2% +$9.85K 0.25% 75
2017
Q1 		$540K Sell
7,953
-541
-6% -$38K 0.24% 76
2016
Q4 		$608K Buy
8,494
+1,634
+24% +$121K 0.3% 70
2016
Q3 		$543K Sell
6,860
-9
-0.1% -$731 0.27% 71
2016
Q2 		$573K Sell
6,869
-105
-2% -$9.32K 0.3% 69
2016
Q1 		$641K Buy
6,974
+160
+2% +$14.4K 0.34% 67
2015
Q4 		$690K Buy
6,814
+115
+2% +$12K 0.39% 64
2015
Q3 		$658K Buy
6,699
+175
+3% +$19.4K 0.39% 62
2015
Q2 		$763K Buy
6,524
+570
+10% +$62.3K 0.42% 56
2015
Q1 		$585K Buy
+5,954
New +$605K 0.32% 67
2014
Q3 		– Sell
-2,484
Closed -$206K – 106
2014
Q2 		$206K Buy
+2,484
New +$193K 0.13% 104

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ascent Wealth Partners's GILD Position: Q1 2026 in Review

Ascent Wealth Partners opened a new position in Gilead Sciences (GILD) in Q1 2026: 57,344 shares worth $7.99M. The stake represents 0.93% of the portfolio and ranks #34 among its holdings. This is a return to the name: Ascent Wealth Partners previously reported a position in GILD as recently as Q4 2017.

Ascent Wealth Partners first reported a position in GILD in Q2 2014 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Ascent Wealth Partners held 57,344 shares of Gilead Sciences worth $7.99M as of Q1 2026.
  • Gilead Sciences was a new Ascent Wealth Partners position in Q1 2026.
  • Gilead Sciences made up 0.93% of Ascent Wealth Partners's portfolio in Q1 2026, its #34 holding.
  • Ascent Wealth Partners first reported a position in Gilead Sciences in Q2 2014 and has held it in 14 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ascent Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.